1158-57 Vascular access site complication post percutaneous coronary intervention  by Hurley, Edward J et al.
JACC March 3, 2004 ABSTRACTS - Angiography & Interventional Cardiology  95A
Angiography &
 Interventional Cardiology
matched between non-dilated and dilated vessels. Differential expression of 12 proteins
was observed between the groups and direct sequencing of digested peptides demon-
strated that these proteins regulate the structural integrity of the vessel wall. Rapamycin
blocked the expression of specific proteins, including lamin A, vimentin, alpha-1-antit-
rypsin, and alpha-actin. In addition, rapamycin significantly reduced the deposition of
elastin, collagen III and fibronectin within the vascular wall. Neointimal formation was like-
wise decreased and this (0.71±0.1 vs 1.4±0.12 intima-media-ratio, rapamycin vs. vehicle,
respectively) could be attributed to the inhibitory properties of rapamycin on ECM deposi-
tion and smooth muscle cell proliferation.
Proteomic profiling of restenotic lesions unveils differential expression of structural pro-
teins that regulate vessel wall integrity. Intramural infusion of rapamycin directly to the
injured site differentially blocked the expression of these proteins as well as smooth mus-
cle cell proliferation and the deposition of ECM, providing a rationale for the use of rapa-
mycin to prevent unfavorable remodeling of the vascular wall that occurs following
angioplasty.
1158-53 Suppressive Effects of Eplerenone on Accumulation of 
Extra Cellular Matrix in Neointima After Coronary Stent 
Implantation Using Swine
Kohei Wakabayashi, Hiroshi Suzuki, Yoshitaka Iso, Nobuyuki Shimizu, Masayuki Shibata, 
Yoichi Takeyama, Fujigaoka Hospital, Yokohama, Japan, Showa University, Tokyo, Japan
Background: Neointimal formation, mainly composed of smooth muscle cell proliferation,
is principle cause of restenosis after coronary stent implantation. However increasing evi-
dence suggests that accumulation of extra cellular matrix_including collagen is also an
important for neointimal formation. Importance of aldosterone on myocardial fibrosis in
heart failure has been reported, but the effects of aldosterone on restenosis after stenting
have not been established. We examined the suppressive effects of eplerenone, new
type of strong aldosterone receptor antagonist, on the neointimal formation after coro-
nary stenting using swine model. Methods: Palmatz-shatz stent (3.0 mm in diameter)
were implanted on the left anterior descending artery for 20 pigs aged 10 weeks weigh-
ing from 20 to 25kg.Those were divided for two groups (Group E; oral administration of
eplerenone 200 mg/day from 1 week before to 4 weeks after stenting. Group C; oral
administration of placebo). Pigs were sacrificed 2 weeks or 4 weeks after stenting. Sam-
ples were embedded in paraffin for histological examination. Masson’s trichrome staining
was used for the assessment of collagen deposition and measurement of %fibrosis area.
Anti-α-smooth muscle actin, anti-proliferative cell nuclear antigen (PCNA) and anti-mac-
rophage antibodies were used for immunohistochemical examinations. Results: Newly
formed neointima was observed in 2 weeks and was become thicker in 4 weeks. Part of
endothelial cells was recovered in 4 weeks in both groups. In neointima, %fibrosis area
was significantly smaller in Group E (33.7±15.8 %) than in Group C (40.7±11.8
%)(p<0.05) in 2 weeks and in Group E (31.3±7.3%) than in Group C (40.4±9.4
%)(p<0.01) in 4 weeks.Therefore the %area of α-smooth muscle actin was larger in
Group E than Group C.Positive staining for PCNA was seen in neointima, especially
around stent strut and infiltrating cells including macrophages were mainly observed
around stent strut in 2 weeks, but the number of positive cells was similar in both groups.
Conclusions: Eplerenone suppresses accumulation of extra cellular matrix in neointima
and will be useful to reduce restenosis after coronary stent implantation.
1158-54 Knock-Out of P21 Escapes Radiation-Induced Cell Cycle 
Arrest and Apoptosis in Vascular Smooth Muscle Cell
Hyun-Jai Cho, Hyo-Soo Kim, Hyun-Ju Cho, Jin Sik Park, In-Ho Chae, Byung-Hee Oh, 
Myoung-Mook Lee, Young-Bae Park, Yun-Shik Choi, Seoul National University College of 
Medicine, Seoul, South Korea
Background: Vascular smooth muscle cell (VSMC) proliferation is important in the patho-
genesis of atherosclerosis and restenosis. In spite of delayed catch-up restenosis of
intravascular radiation therapy, the biologic mechanism of radiation failure has not been
well studied. We investigated the escaping mechanisms of radiation-induced cell cycle
arrest and apoptosis
Methods: Using different dosages of gamma radiation, the cell counts, cell cycle, apopto-
sis, expression and activity of cyclin dependent kinase (CDK), and expression of p16, 21,
and 27 were examined with cultured rat and mouse smooth muscle cells.
Results: The cell counts after irradiation with 0, 2, 8, 16 Gray (Gy) (n=9, each) were 3.28,
2.34, 1.94 and 1.30 x105/ml at 24h, and 5.10, 2.00, 1.80 and 1.20 x105/ml at 48h,
respectively. However, the proportion of apoptosis was minimal, at approximately 10 in 1
x 105 cells. The proportions of cells in the G0/G1, S and G2/M phases were 61, 9 and
30% at 12 hours after 16Gy radiation (control in log phase 61, 34 and 5%), and 67, 7 and
26% (control in confluent phase, 78, 12 and 10%) at 48 hours. By immunoblot analysis
and kinase assay, gamma-irradiation with 8 or 16 Gy increased the expression of p21,
negative regulator of cell cycle progression, , and decreased the expression and activity
of CDK2, an important kinase during the later stages of G1/S progression, as well as the
expression and activity of CDK1, which is important in the G2/M phase transition. In con-
trast, radiation did not affect the expression or activity of either CDK4 or CDK6. The cell-
cycle inhibitors, p27 and p16 were not involved in the radiation-induced cell cycle arrest
of VSMCs. When p21 knocked out, VSMC proliferation was enhanced, and radiation
induced cell cycle arrest and apoptosis were not observed.
Conclusions: Gamma radiation could effectively inhibit VSMC proliferation via cell cycle
arrest rather than apoptosis induction, by enhancing p21 expression and suppressing
CDK1 and 2. But, the knock-out of p21 escaped antiproliferative effect of radiation. So
these findings suggest the degree of p21 expression be the important mechanism of radi-
ation failure and delayed catch-up restenosis.
1158-55 Presence of Mature Dendritic Cells to Early 
Postangioplasty Neointima: Markers of Antigen 
Presentation and Anti-Apoptosis
Alexander Jabs, Stefan Krämer, Margaret Forney Prescott, Berndt Lüderitz, Gerhard 
Bauriedel, University of Bonn, Bonn, Germany, Emory University School of Medicine, 
Atlanta, GA
BACKGROUND – Dendritic cells (DCs) were recently reported following vascular injury.
Since information on specific features of DCs during early neointima formation is sparse,
we sought to determine characteristics of these cells with respect to DC maturation, sur-
vival and antigen presentation.
METHODS – Following rat carotid angioplasty, arterial sections at 7 and 28 days post
injury were immunohistochemically examined for S100 and OX-62 as DC markers, CD86
and OX-6 indicating maturation and antigen presentation, Receptor Activator of NF-kB
(RANK) whose activation mediates DC survival, and FK506-binding protein 12
(FKBP12), the intracellular receptor of rapamycin.
RESULTS – At day 7 post angioplasty, the majority of neointimal cells were identified as
DCs. CD86 and OX-6 labeling were observed in the neointima and the neoadventitia,
while DCs remained confined to the neointima. Immunostaining for RANK was consis-
tently found in a pattern similar to DC signaling. Serial sections demonstrated co-expres-
sion of FKBP12 exclusively restricted to neointimal DCs. Despite a considerably thicker
neointima at day 28, DC markers and RANK were confined to the luminal layer of cells.
CD86 and OX-6 also showed a luminal prevalence, while FKBP12 was observed scat-
tered in luminal and deep neointima.
CONCLUSIONS – Mature dendritic cells were the predominant cell type in early neoint-
ima, and demonstrated RANK upregulation thought to promote cell survival. Co-expres-
sion of FKBP12 and dendritic cell markers suggests that dendritic cells may be
considered as principal targets of rapamycin for restenosis prevention.
1158-56 Effects of Wine, Beer, and Whisky on Vascular 
Endothelium and Thrombosis Fibrinolysis System
Ioannis Ntarladimas, Dimitris M. Tousoulis, Charalambos A. Antoniades, Costas 
Tentolouris, Costas Tsioufis, Stella Brilli, Demosthenis Panagiotakos, Christina 
Chrysochoou, Christos Pitsavos, Christodoulos Stefanadis, Hippokration Hospital, 
Athens University, Athens, Greece
Introduction: Evidence suggests that red wine is associated with decrease cardiovascu-
lar risk in general population. It is still unknown whether alcohol or other substances such
as bioflavonoids affect endothelial function and thrombosis/fibrinolysis system. We com-
pared the effects of red wine, white wine, beer and whisky on endothelial function and
thrombosis/fibrinolysis system.
Methods: The population of the study consisted of 80 healthy young individuals (24±1.6
years old). They were randomised into five equally sized groups and received 264 ml red
wine (8 males 8 females), 264 ml white wine (7 males 9 females), 633 ml of beer (7
males 9 females), 79 ml whisky (9 males 7 females), and 250 ml water (8 males 8
females). Forearm blood flow was determined by gauge-strain plethysmography, at base-
line, at 1 hour and 4 hours after intake. Endothelium-dependent dilation (EDD) and
endothelium independent dilation (EID) were confined as the %change of flow from base-
line to the maximum flow during reactive hyperemia or after sublingual nitroglycerin
administration respectively. Plasma levels of vonWillebrand factor (vWF) and tissue plas-
minogen activator (tPA) were determined at baseline at 4 hours after alcohol consump-
tion.
Results: EDD was significantly increased after 1 hour red wine or beer consumption
(from 96.6±9.7% and 73.5±8.4% to 125±13.6% and 93.4% respectively, p<0.05 for both),
while it returned at baseline at 4 hours (100.9±18.8 and 83.7±20.8 respectively, p=NS
compared to baseline). EDD remained unchanged in the other groups (p=NS). vWF was
decreased in the beer and red wine groups (from 65±4.9 and 62.3±3.7 to 56±4.0% and
56.9±3.9% respectively, p<0.05 for both), but not in the other groups. EID and tPA
remained unchanged in all groups.
Conclusions: Acute consumption of red wine or beer and not of white wine and whisky
increases endothelium-dependent dilation, and decreases vWF levels. These findings
indicate that only red wine and beer are associated with improvement of endothelial func-
tion and reduced thrombogeneicity.
1158-57 Vascular Access Site Complications Post Percutaneous 
Coronary Intervention
Edward J. Hurley, Ryan Lennon, Mathew Verghese, Mandeep Singh, David R. Holmes, 
Malcolm R. Bell, Charanjit S. Rihal, Mayo Clinic and Foundation, Rochester, MN
Background: Vascular access site complications can occur after percutaneous coronary
interventions (PCI). Potential contributing factors include antithrombotic regimens, sheath
size, and patient comorbidities. These have evolved significantly over the past decade.
Method: Vascular complications in 16,201 consecutive PCI patients from 1979 to 2002
were assessed using the Mayo Clinic Interventional Registry. The patients were divided
into four groups based on PCI procedure date. Group I (1979-1989), N= 3085, balloon
angioplasty alone was used in the majority. Group II (1990-1995), N=4753, stent era with
vigorous anticoagulation pre and post PCI. Group III (1996-1999), N=4827, antiplatelet
agents replaced oral anticoagulation and glycoprotein IIB-IIIA inhibitor use was initiated.
Group IV (2000-2002), N=3536, use of clopidogrel along with continued use of Glycopro-
tein IIB-IIIA agents.
Results: The patients in Group IV were significantly older, had a larger body mass index
(BMI), a higher percentage of females, diabetes, hypercholesterolemia, and hypertension
compared to the other three groups. Sheath size used in Group IV was significantly
smaller (French size) compared to Groups II & III (6.4 +/- 0.8 vs 8.2 +/- 0.7 & 7.8 +/- 0.9
respectively; P<.001). The use of glycoprotein IIB-IIIA inhibitors was significantly greater
in Group IV compared to Groups II & III (67% vs 0% & 42% respectively; P<.001). Even
96A ABSTRACTS - Angiography & Interventional Cardiology JACC March 3, 2004
An
gi
og
ra
ph
y 
&
 In
te
rv
en
tio
na
l C
ar
di
ol
og
y
though Group IV patients had more comorbidies, they had significantly less hematoma
formation compared to Groups II & III (2.5% vs 6.4% & 4.0% respectively; P<.001), a sig-
nificantly lower percent of femoral bleeds (0.7% vs 1.7% for Group II; P<.001 & 1.2% for
Group III; P<.025), and significantly lower percent of hypotension (5.9% vs 9.0% & 9.3%
respectively; P<.001). Using multivariate analysis sheath size, age, BMI, and Group were
found to be associated with vascular complications.
Conclusions: The trend of performing transfemoral PCI on older, larger, and greater per-
centage of female patients with more comorbidities continues, but vascular complication
rates have declined. Smaller access sheaths, and possibly refinement of adjunctive phar-
macotherapy have contributed to this decline.
1158-58 Treatment of True Bifurcation Lesions With the 
Simultaneous Kissing Stent Technique
Samin K. Sharma, Angelica M. Steinheimer, Marybeth Duffy, Johnny Lee, Michael C. 
Kim, Edward Fisher, Annapoorna S. Kini, Mount Sinai Medical Center, New York, NY
Background - Bifurcation lesions (BL) involving both branches remain a challenging sub-
set to interventionalist due to plaque shift, difficulty in crossing the stent struts, incom-
plete coverage of the side-branch (SB) ostium and high restenosis rate.
Methods and results - Simultaneous Kissing Stent (SKS) technique involves deployment
of two appropriately sized (1:1 stent-to-artery) stents for both the main vessel (MV) and
SB, with an overlap of the two stents in the proximal segment of MV. We analyzed our
first 100 consecutive patients who underwent SKS for 101 BL (using 202 stents) and
compared with 100 BL undergoing conventional stent strategy (CSS) technique (stent in
MV in all, and stent in SB in 32) matched for the vessel type and SB size (>2.5mm). BL
involved LMCA in 14, LAD in 57, LCX in 14 and RCA in 16 patients. Procedural success
was 100% for MV and 99% for SB in SKS technique, while in CSS group it was 100% for
MV and 92% for SB. In-hospital and 30-days major adverse cardiac events (MACE) were
higher in the CSS versus SKS group, 1% versus 6% (p = 0.05) and 2% versus 8% (p =
0.06) respectively. At mid-term follow-up (152±32 days) TLR was 3% in SKS group vs.
18% in CSS group (p = 0.007).
Conclusion - SKS technique seems to be rapid, safe and effective for treatment of
medium-to-large size BL with very low acute complications and promising mid-term
results compared to CSS. Based on these encouraging results, a multi-center random-
ized trial using DES in BL with SKS technique versus CSS is being planned.
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852-1 Clinical Outcomes in Coronary Angioplasty Centers 
With Off-Site Versus On-Site Cardiac Surgery 
Capabilities: A Preliminary Report From the American 
College of Cardiology - National Cardiovascular Data 
Registry
Michael A. Kutcher, Lloyd W. Klein, Thomas P. Wharton, Robert J. Applegate, Ralph G. 
Brindis, Richard E. Shaw, William S. Weintraub, American College of Cardiology - 
National Cardiovascular Data Registry, Bethesda, MD
Background: Recent reports on the efficacy of primary coronary angioplasty (PCI) for
acute myocardial infarction (MI) and the reduced emergency surgery rates in elective PCI
have created a growing interest in developing PCI centers that do not have on site car-
diac surgery. There is little comparative data to determine whether this is a safe and
effective strategy.
Methods: Clinical features and outcomes in 278,105 consecutive PCI procedures from
304 institutions enrolled in the ACC-NCDR from 1/1/01–3/31/03 were analyzed in centers
with off site (2,537 patients at 17 sites) vs on site surgery (275,568 patients at 287 sites).
Results: Both groups were similar, except for more class III, IV angina (72% vs 70%
p=0.006), prior MI (29% vs 24% p<0.0001), prior CABG (19% vs 13% p<0.0001) and
prior PCI (35% vs 26% p<0.0001) in the on site group. Centers with off site backup had
more acute MI (34% vs 28% p<0.0001), shock (3% vs 2% p=0.003), and urgent/emer-
gent/salvage (69% vs 46% p<0.0001). Outcomes based on whether or not there was an
initial presentation of MI are shown: 
Conclusion: In PCI centers with off site surgical backup, results may approach those of
centers with on site surgery. However, this is a preliminary analysis without risk stratifica-
tion and based on limited data from only 17 off site centers constituting 5.6% of the cen-
ters and 0.91% of the patients in this ACC-NCDR analysis. Off site PCI programs should
participate in the ACC-NCDR to assure that this strategy is fairly assessed and moni-
tored on a national level.
4:15 p.m.
852-2 Elective Percutaneous Coronary Intervention Without 
On-Site Surgery: Inability of Preprocedural 
Characteristics to Accurately Identify Low Risk Patients
Michael Gen, Kevin E. Kip, Helen A. Vlachos, Howard A. Cohen, David O. Williams, 
Rhode Island Hospital, Providence, RI
Background: Immediate access to coronary artery bypass surgery (CABG) has been a
requisite for performing PCI. However advances in PCI technology and selecting only low
risk pts, might allow elective PCI pts to be treated safely without on-site CABG.
Methods: We determined if clinical or angiographic features associated with emergency
CABG in elective PCI pts could be identified. The study cohort included 3819 elective
CSS technique
(n = 100)
SKS technique
(n = 101)
P
MV reference vessel size (mm) 3.5±0.4 3.5±0.6 NS
Any MV debulking (%) 38 24 0.03
-Rotablator 34 21 0.04
-Cutting balloon 4 3 0.70
SB reference vessel size (mm) 2.7±0.3 2.7±0.4 NS
Any SB debulking (%) 44 56 0.21
-Rotablator 6 4 0.51
-Cutting balloon 38 52 <0.01
Stenting (%)
-Main vessel 100 100 NS
-Side-branch 32 100 <0.01
Maximal infl pressure (atm)
Main vessel 18±4 13±3 <0.01
Side-branch 15±3 11±2 <0.01
Total number of stents for BL 148 202 NA
Drug eluting stents (%) 24 28 0.51
Additional lesion intervention 18 16 0.70
Total procedure time (minutes) 62±18 32±12 <0.001
TOTAL OFF SITE ON SITE P value
TOTAL n= 278,105 2,537 275,568
Successful % 91 91 91 0.83
Emerg Surg % 0.73 0.39 0.73 0.06
Death % 1.34 1.69 1.33 0.14
MI Absent n= 200,223 1,668 198,555
Successful % 91 92 91 0.11
Emerg Surg % 0.62 0.24 0.62 0.07
Death % 0.46 0.54 0.46 0.79
Non ST MI n= 38,383 378 38,005
Successful % 90 87 90 0.08
Emerg Surg % 0.83 0 0.83 0.13
Death % 2.23 2.65 2.23 0.71
ST elev MI n= 39,430 491 38,939
Successful % 91 90 91 0.63
Emerg Surg % 1.19 1.22 1.19 0.94
Death % 4.89 4.89 4.89 1
